{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:28:08Z","timestamp":1793946488547,"version":"4.8.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:00:00Z","timestamp":1793318400000},"content-version":"vor","delay-in-days":121,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC\/TRR167"],"award-info":[{"award-number":["CRC\/TRR167"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC740"],"award-info":[{"award-number":["CRC740"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017268","name":"Berlin Institute of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.expneurol.2026.115709","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:38:00Z","timestamp":1773851880000},"page":"115709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Rapamycin treatment reduces CD11c+ microglia and increases amyloid plaque load in 5xFAD mice"],"prefix":"10.1016","volume":"401","author":[{"given":"Koliane","family":"Ouk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Fern\u00e1ndez-Klett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Schormann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Santaella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Fern\u00e1ndez-Zapata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chotima","family":"B\u00f6ttcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Kr\u00fcger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Priller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2026.115709_bb0005","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.neurobiolaging.2014.01.003","article-title":"Migration of neutrophils targeting amyloid plaques in Alzheimer\u2019s disease mouse model","volume":"35","author":"Baik","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2026.115709_bb0010","series-title":"Methods of Behavior Analysis in Neuroscience","article-title":"Anxiety-related behaviors in mice","author":"Bailey","year":"2009"},{"key":"10.1016\/j.expneurol.2026.115709_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54779-w","article-title":"Homeostatic microglia initially seed and activated microglia later reshape amyloid plaques in Alzheimer\u2019s disease","volume":"15","author":"Balig\u00e1cs","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2026.115709_bb0020","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/brain\/awae126","article-title":"Seizures exacerbate excitatory: inhibitory imbalance in Alzheimer's disease and 5XFAD mice","volume":"147","author":"Barbour","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2026.115709_bb0025","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neurobiolaging.2021.02.012","article-title":"Astrogliosis and episodic memory in late life: higher GFAP is related to worse memory and white matter microstructure in healthy aging and Alzheimer\u2019s disease","volume":"103","author":"Bettcher","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2026.115709_bb0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/alzrt36","article-title":"The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer\u2019s disease: oligomer size or conformation?","volume":"2","author":"Broersen","year":"2010","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.expneurol.2026.115709_bb0035","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1080\/15548627.2019.1615823","article-title":"Rapamycin and Alzheimer disease: a double-edged sword?","volume":"15","author":"Carosi","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.expneurol.2026.115709_bb0040","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.expneurol.2018.09.011","article-title":"Early intrathecal infusion of everolimus restores cognitive function and reduces amyloid-\u03b2 and tau pathology in 3xTg-AD mice","volume":"311","author":"Cassano","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2026.115709_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.982786","article-title":"Immunoproteasomes control activation of innate immune signaling and microglial function","volume":"13","author":"\u00c7etin","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.expneurol.2026.115709_bb0050","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202717","article-title":"Microglia in Alzheimer\u2019s disease at single-cell level. Are there common patterns in humans and mice?","volume":"218","author":"Chen","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2026.115709_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242015064","article-title":"Effect sizes of cognitive and locomotive behavior tests in the 5XFAD-J mouse model of Alzheimer\u2019s disease","volume":"24","author":"Choi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2026.115709_bb0060","doi-asserted-by":"crossref","first-page":"12749","DOI":"10.1021\/bi030029q","article-title":"Self-assembly of A\u03b2 into globular neurotoxins","volume":"42","author":"Chromy","year":"2003","journal-title":"Biochemistry-Us"},{"issue":"30","key":"10.1016\/j.expneurol.2026.115709_bb0065","article-title":"mTOR signaling and Alzheimer\u2019s disease: what we know and where we are?","volume":"2022","author":"Davoody","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.expneurol.2026.115709_bb0070","doi-asserted-by":"crossref","first-page":"9874","DOI":"10.1021\/jacs.6b04207","article-title":"Proteasome subunit selective activity-based probes report on proteasome core particle composition in a native polyacrylamide gel electrophoresis fluorescence-resonance energy transfer assay","volume":"138","author":"de Bruin","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.expneurol.2026.115709_bb0075","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.bcp.2009.06.097","article-title":"Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation","volume":"78","author":"Dello Russo","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.expneurol.2026.115709_bb0080","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.3390\/cells13242069","article-title":"Distinct UPR and autophagic functions define cell-specific responses to proteotoxic stress in microglial and neuronal cell lines","volume":"13","author":"Dom\u00ednguez-Mart\u00edn","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.expneurol.2026.115709_bb0085","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.nbd.2006.12.003","article-title":"Rapamycin is a neuroprotective treatment for traumatic brain injury","volume":"26","author":"Erlich","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2026.115709_bb0090","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.expneurol.2026.115709_bb0095","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.267pe24","article-title":"The pharmacology of mTOR inhibition","volume":"2","author":"Guertin","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.expneurol.2026.115709_bb0100","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3 inflammasome is involved in the innate immune response to amyloid-\u03b2","volume":"9","author":"Halle","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.expneurol.2026.115709_bb0105","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nature08221","article-title":"Rapamycin fed late in life extends lifespan in genetically heterogeneous mice","volume":"460","author":"Harrison","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2026.115709_bb0110","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2026.115709_bib356","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuropharm.2014.05.032","article-title":"Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance","volume":"85","author":"Jiang","year":"2014","journal-title":"Neuropharmacology"},{"issue":"476","key":"10.1016\/j.expneurol.2026.115709_bb0115","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar4289","article-title":"Rapamycin and Alzheimer\u2019s disease: time for a clinical trial?","volume":"11","author":"Kaeberlein","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.expneurol.2026.115709_bb0120","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.bbadis.2016.07.007","article-title":"Transcriptional profiling of CD11c-positive microglia accumulating around amyloid plaques in a mouse model for Alzheimer\u2019s disease","volume":"1862","author":"Kamphuis","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"1276\u20131290","key":"10.1016\/j.expneurol.2026.115709_bb0125","article-title":"A unique microglia type associated with restricting development of Alzheimer\u2019s disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2026.115709_bb0130","article-title":"Oral administration of Euonymus alatus leaf extract ameliorates Alzheimer's disease phenotypes in 5xFAD transgenic mice","volume":"13","author":"Kim","year":"2024","journal-title":"Foods"},{"key":"10.1016\/j.expneurol.2026.115709_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001863","article-title":"Distinguishing between exploratory and confirmatory preclinical research will improve translation","volume":"12","author":"Kimmelman","year":"2014","journal-title":"PLoS Biol."},{"key":"10.1016\/j.expneurol.2026.115709_bb0140","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1471-4159.2010.06608.x","article-title":"Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer\u2019s disease transgenic mice","volume":"113","author":"Kimura","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2026.115709_bb0145","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0197-0186(02)00050-5","article-title":"A\u03b2 toxicity in Alzheimer's disease:: globular oligomers (ADDLs) as new vaccine and drug targets","volume":"41","author":"Klein","year":"2002","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.expneurol.2026.115709_bb0150","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1742-2094-9-151","article-title":"Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice","volume":"9","author":"Krstic","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2026.115709_bb0155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.coi.2012.01.005","article-title":"Immunoproteasomes at the interface of innate and adaptive immune responses: two faces of one enzyme","volume":"24","author":"Kr\u00fcger","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.expneurol.2026.115709_bb0160","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10571-016-0386-8","article-title":"Autophagy and Alzheimer\u2019s disease","volume":"37","author":"Li","year":"2017","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2026.115709_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025416","article-title":"Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits","volume":"6","author":"Majumder","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.expneurol.2026.115709_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106295","article-title":"Transcending the amyloid-beta dominance paradigm in Alzheimer\u2019s disease: an exploration of behavioural, metabolic, and gut microbiota phenotypes in 5xFAD mice","volume":"187","author":"Medina-Vera","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2026.115709_bb0175","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neurobiolaging.2004.12.004","article-title":"Immunoproteasome and LMP2 polymorphism in aged and Alzheimer\u2019s disease brains","volume":"27","author":"Mishto","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2026.115709_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175301","article-title":"Pharmacological mTOR-inhibition facilitates clearance of AD-related tau aggregates in the mouse brain","volume":"934","author":"Morawe","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2026.115709_bb0185","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2026.115709_bb0190","article-title":"Age-related deterioration of motor function in male and female 5xFAD mice from 3 to 16 months of age","volume":"19","author":"O\u2019Leary","year":"2020","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.expneurol.2026.115709_bb0195","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/brain\/awt083","article-title":"Reactive glia show increased immunoproteasome activity in Alzheimer's disease","volume":"136","author":"Orre","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2026.115709_bb0200","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.exger.2014.12.002","article-title":"How longevity research can lead to therapies for Alzheimer\u2019s disease: the rapamycin story","volume":"68","author":"Richardson","year":"2015","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.expneurol.2026.115709_bb0205","doi-asserted-by":"crossref","first-page":"633","DOI":"10.14283\/jpad.2023.104","article-title":"Translating the biology of aging into new therapeutics for Alzheimer\u2019s disease: senolytics","volume":"10","author":"Riessland","year":"2023","journal-title":"JPAD-J. Prev. Alzheim."},{"key":"10.1016\/j.expneurol.2026.115709_bb0210","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.expneurol.2026.115709_bb0215","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.42025","article-title":"Microglial SIRPalpha regulates the emergence of CD11c(+) microglia and demyelination damage in white matter","volume":"8","author":"Sato-Hashimoto","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.expneurol.2026.115709_bb0220","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.physbeh.2014.05.041","article-title":"Behavioral and EEG changes in male 5xFAD mice","volume":"135","author":"Schneider","year":"2014","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.expneurol.2026.115709_bb0225","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1523\/JNEUROSCI.2427-21.2022","article-title":"Microglial mTOR activation upregulates Trem2 and enhances beta-amyloid plaque clearance in the 5XFAD Alzheimer\u2019s disease model","volume":"42","author":"Shi","year":"2022","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2026.115709_bb0230","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.nbd.2015.10.001","article-title":"mTOR pathway inhibition prevents neuroinflammation and neuronal death in a mouse model of cerebral palsy","volume":"85","author":"Srivastava","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2026.115709_bb0235","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.bbagen.2009.06.007","article-title":"The TOR pathway comes of age","volume":"1790","author":"Stanfel","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2026.115709_bb0240","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.3389\/fimmu.2019.02900","article-title":"Molecular insight into the IRE1\u03b1-mediated type I interferon response induced by proteasome impairment in myeloid cells of the brain","volume":"10","author":"Studencka-Turski","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.expneurol.2026.115709_bb0245","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12883-024-03596-1","article-title":"Evaluating the effect of rapamycin treatment in Alzheimer\u2019s disease and aging using in vivo imaging: the ERAP phase IIa clinical study protocol","volume":"24","author":"Svensson","year":"2024","journal-title":"BMC Neurol."},{"key":"10.1016\/j.expneurol.2026.115709_bib359","article-title":"Evaluation of rapamycin as a neuroprotective treatment in Alzheimer\u2019s disease: a six-month single-arm open-label clinical pilot trial","author":"Svensson","year":"2025","journal-title":"medRxiv"},{"key":"10.1016\/j.expneurol.2026.115709_bb0250","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nri2546","article-title":"Immunoregulatory functions of mTOR inhibition","volume":"9","author":"Thomson","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.expneurol.2026.115709_bb0255","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s43587-023-00550-7","article-title":"Cerebrospinal fluid proteomics in patients with Alzheimer\u2019s disease reveals five molecular subtypes with distinct genetic risk profiles","volume":"4","author":"Tijms","year":"2024","journal-title":"Nat. Aging"},{"key":"10.1016\/j.expneurol.2026.115709_bb0260","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1750-1326-9-48","article-title":"Oligomeric Abeta-induced synaptic dysfunction in Alzheimer's disease","volume":"9","author":"Tu","year":"2014","journal-title":"Mol. Neurodegener."},{"issue":"649\u2013663","key":"10.1016\/j.expneurol.2026.115709_bb0265","article-title":"TREM2 maintains microglial metabolic fitness in Alzheimer\u2019s disease","volume":"170","author":"Ulland","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2026.115709_bb0270","doi-asserted-by":"crossref","first-page":"H693","DOI":"10.1152\/ajpheart.00570.2017","article-title":"Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer\u2019s disease and vascular cognitive impairment","volume":"314","author":"Van Skike","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.expneurol.2026.115709_bb0275","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13024-016-0118-z","article-title":"Pim1 inhibition as a novel therapeutic strategy for Alzheimer's disease","volume":"11","author":"Velazquez","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2026.115709_bb0280","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/426620a","article-title":"Genetics: influence of TOR kinase on lifespan in C. elegans","volume":"426","author":"Vellai","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2026.115709_bb0285","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00401-015-1386-3","article-title":"Amyloid beta oligomers in Alzheimer\u2019s disease pathogenesis, treatment, and diagnosis","volume":"129","author":"Viola","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2026.115709_bb0290","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40478-017-0453-5","article-title":"Immunoproteasome deficiency alters microglial cytokine response and improves cognitive deficits in Alzheimer\u2019s disease-like APPPS1 mice","volume":"5","author":"Wagner","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.expneurol.2026.115709_bb0295","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1037\/0033-2909.83.3.482","article-title":"The open-field test: a critical review","volume":"83","author":"Walsh","year":"1976","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.expneurol.2026.115709_bb0300","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1016\/j.cell.2022.09.033","article-title":"TREM2 drives microglia response to amyloid-\u03b2 via SYK-dependent and -independent pathways","volume":"185","author":"Wang","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2026.115709_bb0305","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/alzrt107","article-title":"Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer\u2019s disease","volume":"4","author":"Weggen","year":"2012","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.expneurol.2026.115709_bb0310","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1366061","article-title":"Pharmacological mTOR inhibitors in ameliorating Alzheimer\u2019s disease: mechanisms, opportunities, and challenges","volume":"15","author":"Xie","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.expneurol.2026.115709_bb0315","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12974-017-0797-6","article-title":"Everolimus is better than rapamycin in attenuating neuroinflammation and microglial activation in kainic acid and LPS-treated models","volume":"14","author":"Yang","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2026.115709_bb0320","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.neuron.2016.05.003","article-title":"TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy","volume":"90","author":"Yuan","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2026.115709_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106461","article-title":"T cell infiltration mediates neurodegeneration and cognitive decline in Alzheimer\u2019s disease","volume":"193","author":"Zeng","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2026.115709_bb0330","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nature13492","article-title":"Coordinated regulation of protein synthesis and degradation by mTORC1","volume":"513","author":"Zhang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2026.115709_bb0335","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1007\/s12035-023-03904-9","article-title":"Rapamycin alleviates neuronal injury and modulates microglial activation after cerebral ischemia","volume":"61","author":"Zhang","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2026.115709_bb0340","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13024-025-00812-5","article-title":"Peripheral and central neuroimmune mechanisms in Alzheimer\u2019s disease pathogenesis","volume":"20","author":"Zhang","year":"2025","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2026.115709_bb0345","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1080\/15548627.2016.1205770","article-title":"Coordinate regulation of autophagy and the ubiquitin proteasome system by MTOR","volume":"12","author":"Zhao","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.expneurol.2026.115709_bb0350","doi-asserted-by":"crossref","first-page":"15790","DOI":"10.1073\/pnas.1521919112","article-title":"mTOR inhibition activates overall protein degradation by the ubiquitin proteasome system as well as by autophagy","volume":"112","author":"Zhao","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.expneurol.2026.115709_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107540","article-title":"mTORC2 orchestrates monocytic and granulocytic lineage development by regulating proliferation of common myeloid progenitors","volume":"26","author":"Zhao","year":"2023","journal-title":"iScience"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488626000725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488626000725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:45:41Z","timestamp":1793943941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488626000725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":73,"alternative-id":["S0014488626000725"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.115709","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapamycin treatment reduces CD11c+ microglia and increases amyloid plaque load in 5xFAD mice","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.115709","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115709"}}